Skip navigation
Home
News
Products
about IR-World
Team
Customers
Partner
Contact
DE
EN
Communicators
are winners!
Text der Meldung
More News
04.07.2023
Defence and Viewpoint with Dennis Quaid Join Forces to Explore Breakthroughs in Biotechnology
29.06.2023
Defence Therapeutics Inc.: Defence Patent Portfolio at the Forefront of Success
20.06.2023
Defence’s Proprietary Accum(TM) Technology for Delivery of CRISPR/Cas Genome-Editing Complexes Patent Applicaton Published
16.06.2023
Defence Therapeutics - Defence Manufacturing of AccuTOXTM CGMP Final Drug Product Optimization for its Phase I Clinical Trial at City of Hope
06.06.2023
Defence Begins Testing Its Arm Vaccine Against Pancreatic Cancer
24.05.2023
Breakthrough Results: Defence’s Arm Vaccine Cured 100% of Animals with Pre-Established Lymphoma
27.04.2023
USPTO Grants Trademark Registration for Defence Therapeutics®
24.04.2023
Defence Granted US Patent with Broad Coverage on Accum(TM)-based Vaccine Enhancer Platform Technology
18.04.2023
Defence's Novel Accum(TM)-mRNA Vaccine Now Administered for Testing on Cancer
11.04.2023
Defence Breakthrough: Successfully Engineered Accum(TM)-mRNA Vaccine Creating a New Vaccine Platform. The in vivo Accum(TM)-mRNA Cancer Vaccine Program Begins
First
Previous
1
2
3
4
5
6
7
Next
Last